Onesource Specialty Pharma Limited
Biotechnology · Healthcare
Analyst
ICSA Securities
Equibles does not estimate personal net worth.
Abdul Qadir Kuranwala is recorded as Analyst at ICSA Securities. Abdul Qadir Kuranwala has spoken on 2 earnings calls across 2 companies, most recently for Onesource Specialty Pharma Limited on October 27, 2026. Those appearances were for Onesource Specialty Pharma Limited and Alkem Laboratories Limited. The companies whose calls Abdul Qadir Kuranwala spoke on are classified in the Healthcare sector.
“My first question is with regards to the supplies for Dr. B's. Any indication you can provide as to how the ramp-up is happening in terms of the revised APIs, what you would have got, and how are you looking forward for the next six months in terms of the capacity reservation for this client?”
“Sir, my first question is with regards to the trade-generate business. So I understand, you know, it had got impacted because of your receivable policies or your credit period.”
ICSA Securities
Analyst
Transcript header (unverified)
Onesource Specialty Pharma Limited
Biotechnology · Healthcare
Alkem Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Onesource Specialty Pharma Limited
“Alkem Laboratories Limited Q1 FY27 Earnings Conference Call”
Alkem Laboratories Limited